BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 7891013)

  • 21. Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle.
    Davenport AP; O'Reilly G; Molenaar P; Maguire JJ; Kuc RE; Sharkey A; Bacon CR; Ferro A
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S22-5. PubMed ID: 7509950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selectivity of [125I]-PD151242 for human, rat and porcine endothelin ETA receptors in the heart.
    Peter MG; Davenport AP
    Br J Pharmacol; 1995 Jan; 114(2):297-302. PubMed ID: 7881728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [125I]-PD151242: a selective radioligand for human ETA receptors.
    Davenport AP; Kuc RE; Fitzgerald F; Maguire JJ; Berryman K; Doherty AM
    Br J Pharmacol; 1994 Jan; 111(1):4-6. PubMed ID: 8012722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelin expression in the uterus.
    Cameron IT; Bacon CR; Collett GP; Davenport AP
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):209-14. PubMed ID: 7626456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelin Receptors, Mitochondria and Neurogenesis in Cerebral Ischemia.
    Gulati A
    Curr Neuropharmacol; 2016; 14(6):619-26. PubMed ID: 26786146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelin peptides.
    Hirata Y
    Curr Opin Nephrol Hypertens; 1996 Jan; 5(1):12-5. PubMed ID: 8834156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ETA and ETB endothelin receptors in human myometrium characterized by the subtype selective ligands BQ123, BQ3020, FR139317 and PD151242.
    Bacon CR; Morrison JJ; O'Reilly G; Cameron IT; Davenport AP
    J Endocrinol; 1995 Jan; 144(1):127-34. PubMed ID: 7891013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature.
    Davenport AP
    Pharmacol Rev; 2002 Jun; 54(2):219-26. PubMed ID: 12037137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelin.
    Davenport AP; Hyndman KA; Dhaun N; Southan C; Kohan DE; Pollock JS; Pollock DM; Webb DJ; Maguire JJ
    Pharmacol Rev; 2016 Apr; 68(2):357-418. PubMed ID: 26956245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelin receptor antagonism.
    Opgenorth TJ
    Adv Pharmacol; 1995; 33():1-65. PubMed ID: 7495668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelin receptor antagonists: an overview of their synthesis and structure-activity relationship.
    Iqbal J; Sanghia R; Das SK
    Mini Rev Med Chem; 2005 Apr; 5(4):381-408. PubMed ID: 15853628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The current endothelin receptor classification: time for reconsideration?
    Bax WA; Saxena PR
    Trends Pharmacol Sci; 1994 Oct; 15(10):379-86. PubMed ID: 7809954
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.